Mycophenolate mofetil in the treatment of retroperitoneal fibrosis

Fareeha Khalil, M. A. Mir, Rocco C. Venuto

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The pathogenesis of idiopathic retroperitoneal fibrosis (IRPF) has been attributed to an autoimmune response to atherosclerotic lipid material leaking from blood vessels. Corticosteroids and cytotoxic agents have been used for therapy. Based on the immunosuppressive and anti-fibrotic action of mycophenolate, we administered this agent to a patient with biopsy-proven IRPF and achieved a rapid, complete and sustained remission with a 6-year follow-up.

Original languageEnglish (US)
Pages (from-to)679-681
Number of pages3
JournalClinical Rheumatology
Volume27
Issue number5
DOIs
StatePublished - May 1 2008

Fingerprint

Mycophenolic Acid
Retroperitoneal Fibrosis
Cytotoxins
Immunosuppressive Agents
Autoimmunity
Blood Vessels
Adrenal Cortex Hormones
Lipids
Biopsy
Therapeutics

All Science Journal Classification (ASJC) codes

  • Rheumatology

Cite this

Khalil, Fareeha ; Mir, M. A. ; Venuto, Rocco C. / Mycophenolate mofetil in the treatment of retroperitoneal fibrosis. In: Clinical Rheumatology. 2008 ; Vol. 27, No. 5. pp. 679-681.
@article{cb393529b64340d5b2fe55b71e4767d6,
title = "Mycophenolate mofetil in the treatment of retroperitoneal fibrosis",
abstract = "The pathogenesis of idiopathic retroperitoneal fibrosis (IRPF) has been attributed to an autoimmune response to atherosclerotic lipid material leaking from blood vessels. Corticosteroids and cytotoxic agents have been used for therapy. Based on the immunosuppressive and anti-fibrotic action of mycophenolate, we administered this agent to a patient with biopsy-proven IRPF and achieved a rapid, complete and sustained remission with a 6-year follow-up.",
author = "Fareeha Khalil and Mir, {M. A.} and Venuto, {Rocco C.}",
year = "2008",
month = "5",
day = "1",
doi = "10.1007/s10067-007-0826-4",
language = "English (US)",
volume = "27",
pages = "679--681",
journal = "Clinical Rheumatology",
issn = "0770-3198",
publisher = "Springer London",
number = "5",

}

Mycophenolate mofetil in the treatment of retroperitoneal fibrosis. / Khalil, Fareeha; Mir, M. A.; Venuto, Rocco C.

In: Clinical Rheumatology, Vol. 27, No. 5, 01.05.2008, p. 679-681.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Mycophenolate mofetil in the treatment of retroperitoneal fibrosis

AU - Khalil, Fareeha

AU - Mir, M. A.

AU - Venuto, Rocco C.

PY - 2008/5/1

Y1 - 2008/5/1

N2 - The pathogenesis of idiopathic retroperitoneal fibrosis (IRPF) has been attributed to an autoimmune response to atherosclerotic lipid material leaking from blood vessels. Corticosteroids and cytotoxic agents have been used for therapy. Based on the immunosuppressive and anti-fibrotic action of mycophenolate, we administered this agent to a patient with biopsy-proven IRPF and achieved a rapid, complete and sustained remission with a 6-year follow-up.

AB - The pathogenesis of idiopathic retroperitoneal fibrosis (IRPF) has been attributed to an autoimmune response to atherosclerotic lipid material leaking from blood vessels. Corticosteroids and cytotoxic agents have been used for therapy. Based on the immunosuppressive and anti-fibrotic action of mycophenolate, we administered this agent to a patient with biopsy-proven IRPF and achieved a rapid, complete and sustained remission with a 6-year follow-up.

UR - http://www.scopus.com/inward/record.url?scp=41849118449&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=41849118449&partnerID=8YFLogxK

U2 - 10.1007/s10067-007-0826-4

DO - 10.1007/s10067-007-0826-4

M3 - Article

C2 - 18185904

AN - SCOPUS:41849118449

VL - 27

SP - 679

EP - 681

JO - Clinical Rheumatology

JF - Clinical Rheumatology

SN - 0770-3198

IS - 5

ER -